How many studies have been conducted on Sofosbuvir?

BiohacksAI has indexed 296 PubMed studies on Sofosbuvir, including 42 randomized controlled trials (RCTs). 76% of studies involve human subjects.

What are the main research areas for Sofosbuvir?

The primary research domains for Sofosbuvir are 🫁 Liver & Detox, 🛡️ Immunity, 🫘 Kidney. This is based on analysis of 296 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Sofosbuvir

A uridine monophosphate analog inhibitor of HEPATITIS C VIRUS (HCV) polymerase NS5B that is used as an ANTIVIRAL AGENT in the treatment of CHRONIC HEPATITIS C.

296+ PubMed studies analyzed · 42 RCTs · Evidence Score: 55.2

Research Domains

Sofosbuvir has been studied across 10 research domains including 🫁 Liver & Detox, 🛡️ Immunity, 🫘 Kidney, 🏋️ Muscle & Hypertrophy, 🧠 Focus & Attention. The primary research focus is 🫁 Liver & Detox with 20% of studies addressing this area.

Loading evidence profile...

This evidence profile for Sofosbuvir is generated deterministically from 296 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.